Related Experiment Video
Updated: Mar 12, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Congenital Heart Disease in Premature Infants 25-32 Weeks' Gestational Age
Patricia Y Chu1, Jennifer S Li2, Andrzej S Kosinski3
1Duke University School of Medicine, Durham, NC.
Insights
Congenital heart defects (CHDs) are more common in premature infants, significantly increasing their mortality risk. Early intervention and efforts to prevent premature birth are crucial for affected infants.
Area of Science:
- Neonatalogy
- Pediatric Cardiology
- Public Health
Background:
- Congenital heart defects (CHDs) are a significant concern in neonatal care.
- Premature infants face unique challenges, and the prevalence and impact of CHDs in this population require detailed investigation.
Purpose of the Study:
- To determine the birth prevalence of congenital heart defects (CHDs) in very/extremely premature infants.
- To compare mortality rates between premature infants with and without CHDs.
Main Methods:
- Utilized the Kids' Inpatient Databases (2003-2012).
- Estimated birth prevalence of CHDs (excluding PDA) in infants born between 25-32 weeks gestational age.
- Employed multivariable logistic regression to assess mortality risks.
Main Results:
- Identified 28,806 CHDs among 249,011 very/extremely premature infants; overall prevalence was 116 per 1000 births.
- Severe CHDs were significantly more prevalent in premature infants (7.4 per 1000) compared to term infants (1.5 per 1000).
- Premature infants with severe CHDs had a 26.3% in-hospital mortality and a 7.5-fold increased odds of death; mortality varied by defect type.
Conclusions:
- Increased prevalence and mortality of severe CHDs in premature infants underscore the need for targeted interventions.
- Intensive interventions to decrease premature delivery are warranted for pregnancies diagnosed with fetal CHD.
Objective:
To determine the birth prevalence of congenital heart defects (CHDs) across the spectrum of common defects in very/extremely premature infants and to compare mortality rates between premature infants with and without CHDs.
Study Design:
The Kids' Inpatient Databases (2003-2012) were used to estimate the birth prevalence of CHDs (excluding patent ductus arteriosus) in very/extremely premature infants born between 25 and 32 weeks' gestational age. Birth prevalence was compared with term infants for a subset of "severe" defects expected to be near universally diagnosed in the neonatal period. Weighted multivariable logistic regression was used to calculate aORs of mortality comparing very and extremely premature infants with vs without CHDs.
Results:
We identified 249 011 very/extremely premature infants, including 28 806 with CHDs. The overall birth prevalence of CHDs was 116 per 1000 very/extremely premature births. Severe CHDs had significantly higher birth prevalence in very/extremely premature infants when compared with term infants (7.4 per 1000 very/premature births vs 1.5 per 1000 term births; P < .001). Very/extremely premature infants with severe CHDs had an overall 26.3% in-hospital mortality and a 7.5-fold increased adjusted odds of death compared with those without CHDs. Mortality varied widely by defect in very/extremely premature infants, ranging from 12% for interrupted aortic arch to 67% for truncus arteriosus.
Conclusions:
Given the increased birth prevalence of severe CHDs in very/extremely premature infants, and significantly higher mortality, there is justification for intensive interventions aimed at decreasing the likelihood of premature delivery for patients where CHD is diagnosed in utero.
Related Concept Videos
Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
Teratogenicity
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Valve Prolapse III: Nursing Management
Mitral Stenosis I: Introduction

